Reflect Scientific, Inc. (RSCF)
0.0586
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
Reflect Scientific Enterprise Value : 3.590M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 3.590M |
| October 28, 2026 | 3.442M |
| October 27, 2026 | 3.540M |
| October 26, 2026 | 3.540M |
| October 23, 2026 | 3.540M |
| October 22, 2026 | 3.701M |
| October 21, 2026 | 3.949M |
| October 20, 2026 | 3.949M |
| October 19, 2026 | 3.440M |
| October 16, 2026 | 4.001M |
| October 15, 2026 | 3.966M |
| October 14, 2026 | 3.718M |
| October 13, 2026 | 3.750M |
| October 12, 2026 | 3.324M |
| October 09, 2026 | 3.273M |
| October 08, 2026 | 2.939M |
| October 07, 2026 | 3.152M |
| October 06, 2026 | 3.277M |
| October 05, 2026 | 2.853M |
| October 02, 2026 | 2.646M |
| October 01, 2026 | 3.024M |
| September 30, 2026 | 3.634M |
| September 29, 2026 | 3.701M |
| September 28, 2026 | 3.684M |
| September 25, 2026 | 3.687M |
| Date | Value |
|---|---|
| September 24, 2026 | 3.538M |
| September 23, 2026 | 3.624M |
| September 22, 2026 | 3.966M |
| September 21, 2026 | 3.624M |
| September 18, 2026 | 3.290M |
| September 17, 2026 | 2.99M |
| September 16, 2026 | 2.939M |
| September 15, 2026 | 2.639M |
| September 14, 2026 | 2.082M |
| September 11, 2026 | 2.425M |
| September 10, 2026 | 2.467M |
| September 09, 2026 | 2.168M |
| September 08, 2026 | 2.168M |
| September 04, 2026 | 2.168M |
| September 03, 2026 | 2.442M |
| September 02, 2026 | 2.442M |
| September 01, 2026 | 2.442M |
| August 31, 2026 | 2.707M |
| August 28, 2026 | 2.544M |
| August 27, 2026 | 2.853M |
| August 26, 2026 | 2.763M |
| August 25, 2026 | 2.459M |
| August 24, 2026 | 3.007M |
| August 21, 2026 | 3.016M |
| August 20, 2026 | 2.832M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 28.92B |
| Agilent Technologies, Inc. | 53.27B |
| Anika Therapeutics, Inc. | 278.45M |
| Bio-Rad Laboratories, Inc. | 10.03B |
| Bruker Corp. | 11.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0928M |
| Revenue (Quarterly) | 0.4162M |
| Total Expenses (Quarterly) | 0.3234M |
| EPS Diluted (Quarterly) | 0.0011 |
| Gross Profit Margin (Quarterly) | 42.89% |
| Profit Margin (Quarterly) | 22.30% |
| Earnings Yield | 6.48% |
| Operating Earnings Yield | 5.37% |
| Normalized Earnings Yield | 6.485 |